CARCINOMA, NON-SMALL-CELL LUNG
Clinical trials for CARCINOMA, NON-SMALL-CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, NON-SMALL-CELL LUNG trials appear
Sign up with your email to follow new studies for CARCINOMA, NON-SMALL-CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis Phase 2 trial tests whether giving a combination of amivantamab and either lazertinib or chemotherapy before surgery can shrink or stop the growth of EGFR-mutated non-small cell lung cancer. About 68 people with stage II-IIIB lung cancer that can be surgically removed will p…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for hard-to-treat cancers? experimental combo enters phase 2 trial
Disease control Not yet recruitingThis study tests a new drug (GV20-0251) combined with an immunotherapy (anti-PD-1) in people with advanced solid tumors that have not responded to or cannot tolerate standard treatments. About 227 adults with various cancers, including lung, breast, and colorectal, will participa…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG
Phase: PHASE2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could existing cancer drugs tackle rare tumors? new trial aims to find out
Disease control Not yet recruitingThis trial tests whether two approved drugs, dabrafenib and trametinib, can treat rare cancers that have a specific genetic change called BRAF V600. These drugs are already used for melanoma and lung cancer, but researchers want to see if they help people with other cancer types.…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can less be more? new study tests smaller lung surgery after immunotherapy
Disease control Not yet recruitingThis study looks at whether a smaller lung surgery after immunotherapy works as well as the standard larger surgery for people with stage II-IIIB non-small cell lung cancer. About 354 patients whose tumors shrank with immunotherapy will choose either a limited or conventional sur…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New MRI technique aims to spare healthy lung during cancer radiation
Disease control Not yet recruitingThis early-phase trial tests whether a special MRI scan using hyperpolarized xenon gas can help doctors plan radiation treatment for non-small cell lung cancer. The goal is to deliver enough radiation to the tumor while avoiding healthy lung tissue, which could reduce side effect…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG
Phase: PHASE1, PHASE2 • Sponsor: Xemed LLC • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Cheaper keytruda copycat tested in lung cancer patients
Disease control Not yet recruitingThis phase 3 trial tests QL2107, a biosimilar (copy) of the cancer drug Keytruda, in 122 adults with non-small cell lung cancer that has been surgically removed. The goal is to see if the body processes QL2107 the same way as Keytruda when given as an extra treatment after surger…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 14:56 UTC